Prelude Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-185
| Closed | -$9K | – | 1359 |
|
|
2019
Q1 | $9K | Sell |
185
-28
| -13% | -$1.36K | ﹤0.01% | 1080 |
|
|
2018
Q4 | $13K | Buy |
213
+73
| +52% | +$4.46K | ﹤0.01% | 982 |
|
|
2018
Q3 | $9K | Buy |
+140
| New | +$9K | ﹤0.01% | 1115 |
|
|
2017
Q4 | – | Sell |
-1,700
| Closed | -$69K | – | 1293 |
|
|
2017
Q3 | $69K | Buy |
1,700
+100
| +6% | +$4.06K | 0.01% | 917 |
|
|
2017
Q2 | $54K | Sell |
1,600
-7,583
| -83% | -$256K | 0.01% | 883 |
|
|
2017
Q1 | $267K | Sell |
9,183
-2,298
| -20% | -$66.8K | 0.03% | 422 |
|
|
2016
Q4 | $377K | Buy |
11,481
+4,088
| +55% | +$134K | 0.05% | 345 |
|
|
2016
Q3 | $233K | Buy |
7,393
+2,817
| +62% | +$88.8K | 0.02% | 470 |
|
|
2016
Q2 | $129K | Sell |
4,576
-698
| -13% | -$19.7K | 0.02% | 616 |
|
|
2016
Q1 | $192K | Buy |
+5,274
| New | +$192K | 0.03% | 509 |
|
|
2015
Q3 | – | Sell |
-2,224
| Closed | -$73K | – | 1454 |
|
|
2015
Q2 | $73K | Buy |
+2,224
| New | +$73K | 0.01% | 935 |
|
|
2015
Q1 | – | Sell |
-1,500
| Closed | -$41K | – | 1898 |
|
|
2014
Q4 | $41K | Sell |
1,500
-5,100
| -77% | -$139K | 0.01% | 1255 |
|
|
2014
Q3 | $141K | Buy |
6,600
+500
| +8% | +$10.7K | 0.02% | 810 |
|
|
2014
Q2 | $137K | Buy |
6,100
+5,600
| +1,120% | +$126K | 0.02% | 810 |
|
|
2014
Q1 | $13K | Buy |
+500
| New | +$13K | ﹤0.01% | 1557 |
|
|
2013
Q4 | – | Sell |
-340
| Closed | -$6K | – | 1573 |
|
|
2013
Q3 | $6K | Buy |
+340
| New | +$6K | ﹤0.01% | 1285 |
|